{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T01:13:22Z","timestamp":1793150002205,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,10,11]],"date-time":"2017-10-11T00:00:00Z","timestamp":1507680000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1007\/s00011-017-1089-4","type":"journal-article","created":{"date-parts":[[2017,10,11]],"date-time":"2017-10-11T01:40:11Z","timestamp":1507686011000},"page":"21-30","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Glycated albumin (GA) and inflammation: role of GA as a potential marker of inflammation"],"prefix":"10.1007","volume":"67","author":[{"given":"H. Vernon","family":"Roohk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asad R.","family":"Zaidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0235-5174","authenticated-orcid":false,"given":"Dimple","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,11]]},"reference":[{"key":"1089_CR1","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.cca.2013.07.013","volume":"425","author":"J Anguizola","year":"2013","unstructured":"Anguizola J, Matsuda R, Barnaby OS. Review: glycation of human serum albumin. Clin Chim Acta. 2013;425:64\u201376. doi:\n                        10.1016\/j.cca.2013.07.013\n                        \n                    .","journal-title":"Clin Chim Acta"},{"key":"1089_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2013.05.010","author":"N Furusyo","year":"2013","unstructured":"Furusyo N, Hayashi J. Glycated albumin and diabetes mellitus. Biochim et Biophys Acta (BBA) Gen Subj. 2013. doi:\n                        10.1016\/j.bbagen.2013.05.010\n                        \n                    .","journal-title":"Biochim et Biophys Acta (BBA) Gen Subj"},{"key":"1089_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2016.02.021","author":"T Yajima","year":"2016","unstructured":"Yajima T, Yajima K, Hayashi M, Yasuda K, Takahashi H, Yamakita N. Serum albumin-adjusted glycated albumin is a better predictor of mortality in diabetic patients with end-stage renal disease on hemodialysis. J Diabetes Complicat. 2016. doi:\n                        10.1016\/j.jdiacomp.2016.02.021\n                        \n                    .","journal-title":"J Diabetes Complicat"},{"key":"1089_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17050619","author":"H Kobayashi","year":"2016","unstructured":"Kobayashi H, Abe M, Yoshida Y, Suzuki H, Maruyama N, Okada K. Glycated albumin versus glycated hemoglobin as a glycemic indicator in diabetic patients on peritoneal dialysis. IJMS. 2016. doi:\n                        10.3390\/ijms17050619\n                        \n                    .","journal-title":"IJMS"},{"issue":"6","key":"1089_CR5","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1177\/193229680800200620","volume":"2","author":"VH Roohk","year":"2008","unstructured":"Roohk VH, Zaidi A. A review of glycated albumin as an intermediate glycation index for controlling diabetes. J Diabetes Sci Technol. 2008;2(6):1114\u201321.","journal-title":"J Diabetes Sci Technol"},{"key":"1089_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.04.012","author":"V Arroyo","year":"2014","unstructured":"Arroyo V, Garc\u00eda-Martinez R, Salvatella X. Human serum albumin, systemic inflammation, and cirrhosis. J Hepatol. 2014. doi:\n                        10.1016\/j.jhep.2014.04.012\n                        \n                    .","journal-title":"J Hepatol"},{"key":"1089_CR7","doi-asserted-by":"publisher","first-page":"S40","DOI":"10.1046\/j.1523-1755.2000.07707.x","volume":"58","author":"S Chen","year":"2000","unstructured":"Chen S, Cohen MP, Ziyadeh FN. Amadori-glycated albumin in diabetic nephropathy: pathophysiologic connections. Kidney Int. 2000;58:S40\u20134. doi:\n                        10.1046\/j.1523-1755.2000.07707.x\n                        \n                    .","journal-title":"Kidney Int"},{"key":"1089_CR8","doi-asserted-by":"publisher","DOI":"10.1172\/JCI29069","author":"SE Shoelson","year":"2006","unstructured":"Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Investig. 2006. doi:\n                        10.1172\/JCI29069\n                        \n                    .","journal-title":"J Clin Investig"},{"key":"1089_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2014.04\/006","author":"N Esser","year":"2014","unstructured":"Esser N, Legrand-Poels S, Piette J, Scheen A, Paquot N. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res Clin Pract. 2014. doi:\n                        10.1016\/j.diabres.2014.04\/006\n                        \n                    .","journal-title":"Diabetes Res Clin Pract"},{"key":"1089_CR10","doi-asserted-by":"publisher","DOI":"10.2337\/db09-0232","author":"D Su","year":"2009","unstructured":"Su D, Coudriet G, Hyun Kim D, Lu Y, Perdomo G, Qu S, et al. FoxO1 links insulin resistance to proinflammatory cytokine IL-1 production in macrophages. Diabetes. 2009. doi:\n                        10.2337\/db09-0232\n                        \n                    .","journal-title":"Diabetes"},{"key":"1089_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2007.03.022","author":"L Lu","year":"2007","unstructured":"Lu L, Pu L, Xu X, Zhang Q, Zhang R, Zhang J, et al. Association of serum levels of glycated albumin, C-reactive protein and tumor necrosis factor-\u03b1 with the severity of coronary artery disease and renal impairment in patients with type 2 diabetes mellitus. Clin Biochem. 2007. doi:\n                        10.1016\/j.clinbiochem.2007.03.022\n                        \n                    .","journal-title":"Clin Biochem"},{"key":"1089_CR12","doi-asserted-by":"publisher","DOI":"10.2337\/db13-0782","author":"D Nathan","year":"2013","unstructured":"Nathan D, McGee P, Steffes M, Lachin J. Relationship of glycated albumin to blood glucose and HbA1c values and to retinopathy, nephropathy, and cardiovascular outcomes in the DCCT\/EDIC study. Diabetes. 2013. doi:\n                        10.2337\/db13-0782\n                        \n                    .","journal-title":"Diabetes"},{"key":"1089_CR13","doi-asserted-by":"publisher","DOI":"10.1253\/circj.71.1067","author":"L Pu","year":"2007","unstructured":"Pu L, Lu L, Shen W, Zhang Q, Zhang R, Zhang J, et al. Increased serum glycated albumin level is associated with the presence and severity of coronary artery disease in type 2 diabetic patients. Circ J. 2007. doi:\n                        10.1253\/circj.71.1067\n                        \n                    .","journal-title":"Circ J"},{"key":"1089_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2012.12.018","author":"H Wang","year":"2013","unstructured":"Wang H, Lo W, Lin L. Angiotensin-(1\u20137) decreases glycated albumin-induced endothelial interleukin-6 expression via modulation of miR-146a. Biochem Biophys Res Commun. 2013. doi:\n                        10.1016\/j.bbrc.2012.12.018\n                        \n                    .","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"1089_CR15","first-page":"1660","volume":"42","author":"Z Bian","year":"2001","unstructured":"Bian Z. Signaling pathways for glycated human serum albumin-induced IL-8 and MCP-1 secretion in human RPE cells. Investig Ophthalmol Vis Sci. 2001;42(7):1660\u20138.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"1089_CR16","doi-asserted-by":"publisher","DOI":"10.2337\/dc513-3015","author":"RM Pollack","year":"2016","unstructured":"Pollack RM, Donath MY, LeRoith D, Leibowitz F. Anti-inflammatory agents in the treatment of diabetes and its vascular complications. Diabetes Care. 2016. doi:\n                        10.2337\/dc513-3015\n                        \n                    .","journal-title":"Diabetes Care"},{"key":"1089_CR17","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/508409","author":"L Chen","year":"2015","unstructured":"Chen L, Chen R, Wang H, Liang F. Mechanisms linking inflammation to insulin resistance. Int J Endocrinol. 2015. doi:\n                        10.1155\/2015\/508409\n                        \n                    .","journal-title":"Int J Endocrinol"},{"key":"1089_CR18","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.111.241877","author":"F Song","year":"2012","unstructured":"Song F, Schmidt AM. Glycation and insulin resistance: novel mechanisms and unique targets? Arerioscler Thromb Vasc Biol. 2012. doi:\n                        10.1161\/ATVBAHA.111.241877\n                        \n                    .","journal-title":"Arerioscler Thromb Vasc Biol"},{"key":"1089_CR19","doi-asserted-by":"publisher","DOI":"10.1161\/hy1201.097300","author":"Y Hattori","year":"2002","unstructured":"Hattori Y, Suzuki M, Hattori S, Kasai K. Vascular smooth muscle cell activation by glycated albumin (Amadori adducts). Hypertension. 2002. doi:\n                        10.1161\/hy1201.097300\n                        \n                    .","journal-title":"Hypertension"},{"key":"1089_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-015-0247-7","author":"N Mukai","year":"2015","unstructured":"Mukai N, Ninomiya T, Hata J, Hirakawa Y, Ikeda F, Fukuhara M, et al. Association of hemoglobin A1c and glycated albumin with carotid atherosclerosis in community-dwelling Japanese subjects: the Hisayama study. Cardiovasc Diabetol. 2015. doi:\n                        10.1186\/s12933-015-0247-7\n                        \n                    .","journal-title":"Cardiovasc Diabetol"},{"key":"1089_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ehj.2014.11.005","author":"J Auer","year":"2002","unstructured":"Auer J, Berent R, Lassnig E, Eber B. C-reactive protein and coronary artery disease. Jpn Heart J. 2002. doi:\n                        10.1016\/j.ehj.2014.11.005\n                        \n                    .","journal-title":"Jpn Heart J"},{"key":"1089_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2840-5-27","author":"LJ Pu","year":"2006","unstructured":"Pu LJ, Lu L, Xu XW, Zhang RY, Zhang Q, Zhang JS. Value of serum glycated albumin and high-sensitivity-C-reactive protein levels in the prediction of presence of coronary artery disease in patients with type 2 diabetes. Cardiovasc Diabetol. 2006. doi:\n                        10.1186\/1475-2840-5-27\n                        \n                    .","journal-title":"Cardiovasc Diabetol"},{"key":"1089_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-014-0166-z","author":"X Ma","year":"2015","unstructured":"Ma X, Hu X, Zhou J, Hao Y, Luo Y, Lu Z, et al. Glycated albumin is more closely correlated with coronary artery disease than 1,5-anhydroglucitol and glycated hemoglobin A1c. Cardiovasc Diabetol. 2015. doi:\n                        10.1186\/s12933-014-0166-z\n                        \n                    .","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"1089_CR24","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1177\/193229681100500325","volume":"5","author":"D Rubenstein","year":"2011","unstructured":"Rubenstein D, Maria Z, Yin W. Glycated albumin modulates endothelial cell thrombogenic and inflammatory responses. J Diabetes Sci Technol. 2011;5(3):703\u201313.","journal-title":"J Diabetes Sci Technol"},{"key":"1089_CR25","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/918267","author":"G Kolluru","year":"2012","unstructured":"Kolluru G, Bir S, Kevil C. Endothelial dysfunction and diabetes: effects on angiogenesis, vascular remodeling, and wound healing. Int J Vasc Med. 2012. doi:\n                        10.1155\/2012\/918267\n                        \n                    .","journal-title":"Int J Vasc Med"},{"key":"1089_CR26","doi-asserted-by":"publisher","DOI":"10.1055\/s-2002-32042","author":"C Schalkwijk","year":"2002","unstructured":"Schalkwijk C, Lieuw-a-Fa M, van Hinsbergh V, Stehouwer C. Pathophysiological role of amadori-glycated proteins in diabetic microangiopathy. Semin Vasc Med. 2002. doi:\n                        10.1055\/s-2002-32042\n                        \n                    .","journal-title":"Semin Vasc Med"},{"key":"1089_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2014.06.015","author":"J Pan","year":"2014","unstructured":"Pan J, Li Q, Zhang L, Jia L, Tang J, Bao Y, et al. Serum glycated albumin predicts the progression of diabetic retinopathy\u2014a five year retrospective longitudinal study. J Diabetes Complicat. 2014. doi:\n                        10.1016\/j.jdiacomp.2014.06.015\n                        \n                    .","journal-title":"J Diabetes Complicat"},{"key":"1089_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/sj.eye.6701499","author":"S Loukovaara","year":"2004","unstructured":"Loukovaara S, Immonen I, Koistinen R, Hiilesmaa V, Kaaja R. Inflammatory markers and retinopathy in pregnancies complicated with type I diabetes. Eye. 2004. doi:\n                        10.1038\/sj.eye.6701499\n                        \n                    .","journal-title":"Eye"},{"key":"1089_CR29","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/582060","author":"F Semeraro","year":"2015","unstructured":"Semeraro F, Cancarini A, dell\u2019Omo R, Rezzola S, Romano M, Costagliola C. Diabetic retinopathy: vascular and inflammatory disease. J Diabetes Res. 2015. doi:\n                        10.1155\/2015\/582060\n                        \n                    .","journal-title":"J Diabetes Res"},{"key":"1089_CR30","doi-asserted-by":"publisher","DOI":"10.4172\/2155-9899","author":"S Abcouwer","year":"2011","unstructured":"Abcouwer S. Angiogenic factors and cytokines in diabetic retinopathy. J Clin Cell Immunol. 2011. doi:\n                        10.4172\/2155-9899\n                        \n                    .","journal-title":"J Clin Cell Immunol"},{"key":"1089_CR31","doi-asserted-by":"publisher","DOI":"10.2337\/db10-1160","author":"A Ibrahim","year":"2011","unstructured":"Ibrahim A, El-Remessy A, Matragoon S, Zhang W, Patel Y, Khan S, et al. Retinal microglial activation and inflammation induced by amadori-glycated albumin in a rat model of diabetes. Diabetes. 2011. doi:\n                        10.2337\/db10-1160\n                        \n                    .","journal-title":"Diabetes"},{"key":"1089_CR32","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.15-18224","author":"N Dong","year":"2016","unstructured":"Dong N, Xu B, Shi H, Lu Y. miR-124 regulates Amadori-glycated albumin-induced retinal microglial activation and inflammation by targeting Rac1. Retinal Cell Biol. 2016. doi:\n                        10.1167\/iovs.15-18224\n                        \n                    .","journal-title":"Retinal Cell Biol"},{"key":"1089_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2010.04.084","author":"Y Li","year":"2010","unstructured":"Li Y, Wang S. Glycated albumin activates NADPH oxidase in rat mesangial cells through up-regulation of p47phox. Biochem Biophys Res Commun. 2010. doi:\n                        10.1016\/j.bbrc.2010.04.084\n                        \n                    .","journal-title":"Biochem Biophys Res Commun"},{"key":"1089_CR34","doi-asserted-by":"publisher","DOI":"10.1093\/ndtplus\/sfr140","author":"FE Vos","year":"2011","unstructured":"Vos FE, Schollum JB, Walker RJ. Glycated albumin is the preferred marker for assessing glycemic control in advanced chronic kidney disease. NTD Plus. 2011. doi:\n                        10.1093\/ndtplus\/sfr140\n                        \n                    .","journal-title":"NTD Plus"},{"key":"1089_CR35","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00201.2006","author":"M Cohen","year":"2006","unstructured":"Cohen M, Lautenslager G, Hud E, Shea E, Wang A, Chen S, et al. Inhibiting albumin glycation attenuates dysregulation of VEGFR-1 and collagen IV subchain production and the development of renal insufficiency. AJP Renal Physiol. 2006. doi:\n                        10.1152\/ajprenal.00201.2006\n                        \n                    .","journal-title":"AJP Renal Physiol"},{"key":"1089_CR36","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.00567.x","author":"M Cohen","year":"2005","unstructured":"Cohen M, Chen S, Ziyadeh F, Shea E, Hud E, Lautenslager G, et al. Evidence linking glycated albumin to altered glomerular nephrin and VEGF expression, proteinuria, and diabetic nephropathy. Kidney Int. 2005. doi:\n                        10.1111\/j.1523-1755.2005.00567.x\n                        \n                    .","journal-title":"Kidney Int"},{"key":"1089_CR37","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2005101113","author":"S Tang","year":"2006","unstructured":"Tang S, Leung J, Chan L, Tsang A, Lai KN. Activation of tubular epithelial cells in diabetic nephropathy and the role of peroxisome proligerator-activated receptor-\u03b3 agonist. JASN. 2006. doi:\n                        10.1681\/ASN.2005101113\n                        \n                    .","journal-title":"JASN"},{"key":"1089_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2016.01.011","author":"J Park","year":"2016","unstructured":"Park J, Song J, Park Y, Lee S, Lee S. Glycated albumin increases with disease activity in rheumatoid factor positive rheumatoid arthritis patients with normal fasting glucose and HbA1c. Jt Bone Spine. 2016. doi:\n                        10.1016\/j.jbspin.2016.01.011\n                        \n                    .","journal-title":"Jt Bone Spine"},{"key":"1089_CR39","doi-asserted-by":"publisher","DOI":"10.1111\/jre.12194","author":"E Shim","year":"2014","unstructured":"Shim E, Babu J. Glycated albumin produced in diabetic hyperglycemia promotes monocyte secretion of inflammatory cytokines and bacterial adherence to epithelial cells. J Periodontal Res. 2014. doi:\n                        10.1111\/jre.12194\n                        \n                    .","journal-title":"J Periodontal Res"},{"issue":"12","key":"1089_CR40","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1172\/JCI200318921","volume":"111","author":"MB Pepys","year":"2003","unstructured":"Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Investig. 2003;111(12):1805\u201312.","journal-title":"J Clin Investig"},{"key":"1089_CR41","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000259897","volume":"31","author":"L Kennedy","year":"2010","unstructured":"Kennedy L, Pilar SM, Meneghini L, Lo M, Cohen MP. Anti-glycation and anti-albuminuric effects of GLY-230 in human diabetes. Am J Nephrol. 2010;31:110\u20136.","journal-title":"Am J Nephrol"},{"key":"1089_CR42","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-016-3873-z","author":"MY Donath","year":"2016","unstructured":"Donath MY. Multiple benefits of targeting inflammation in the treatment of type 2 diabetes. Diabetologia. 2016. doi:\n                        10.1007\/s00125-016-3873-z\n                        \n                    .","journal-title":"Diabetologia"},{"key":"1089_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccs.2014.07.035","author":"M Koga","year":"2015","unstructured":"Koga M, Hirata T, Kasayama S, Ishizaka Y, Yamakado M. Body mass index negatively regulates glycated albumin through insulin secretion in patients with type 2 diabetes mellitus. Clin Chim Acta. 2015. doi:\n                        10.1016\/j.ccs.2014.07.035\n                        \n                    .","journal-title":"Clin Chim Acta"},{"key":"1089_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2006.10.013","author":"M Koga","year":"2007","unstructured":"Koga M, Otsuki M, Matsumoto S, Saito H, Mukai M, Kasayama S. Negative association of obesity and its related chronic inflammation with serum glycated albumin but not glycated hemoglobin levels. Clin Chim Acta. 2007. doi:\n                        10.1016\/j.cca.2006.10.013\n                        \n                    .","journal-title":"Clin Chim Acta"},{"issue":"7","key":"1089_CR45","first-page":"64","volume":"4","author":"A Varghese","year":"2015","unstructured":"Varghese A, Asha NS, Celine TM, Prasanna D. Inflammatory markers in type II diabetes mellitus. Pharm J. 2015;4(7):64\u20136.","journal-title":"Pharm J"},{"key":"1089_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.ehj.2004.09.008","author":"CG Gustavsson","year":"2004","unstructured":"Gustavsson CG, Agardh CD. Markers of inflammation in patients with coronary artery disease are also associated with glycosylated haemoglobin A within the normal range. Eur Heart J. 2004. doi:\n                        10.1016\/j.ehj.2004.09.008\n                        \n                    .","journal-title":"Eur Heart J"},{"key":"1089_CR47","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-1896","author":"T Shafi","year":"2012","unstructured":"Shafi T, Sozio S, Plantinga L, Jaar B, Kim E, Parekh R, et al. Serum fructosamine and glycated albumin and risk of mortality and clinical outcomes in hemodialysis patients. Diabetes Care. 2012. doi:\n                        10.2337\/dc12-1896\n                        \n                    .","journal-title":"Diabetes Care"},{"key":"1089_CR48","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000001134","author":"A DeCoux","year":"2015","unstructured":"DeCoux A, Tian Y, DeLeon-Pennell K, Nguyen N, de Castro Br\u00e1s L, Flynn E, et al. Plasma glycoproteomics reveals sepsis outcomes linked to distinct proteins in common pathways*. Crit Care Med. 2015. doi:\n                        10.1097\/CCM.0000000000001134\n                        \n                    .","journal-title":"Crit Care Med"},{"issue":"3","key":"1089_CR49","first-page":"1122","volume":"71","author":"C Kate","year":"2002","unstructured":"Kate C, Parhar RS, Saleh SS, Meyer BF, Kwaasi AA, Hammami MM, et al. RAGE-mediated neutrophil dysfunction is evoked by advanced glycation end products (AGEs). J Leukoc Biol. 2002;71(3):1122\u201333.","journal-title":"J Leukoc Biol"},{"key":"1089_CR50","doi-asserted-by":"publisher","DOI":"10.1039\/C6MB00324A","author":"K Neelofar","year":"2016","unstructured":"Neelofar K, Arif Z, Alam K, Ahmad J. Hyperglycemia induced structural and functional changes in human serum albumin of diabetic patients: a physico-chemical study. Mol Biosyst. 2016. doi:\n                        10.1039\/C6MB00324A\n                        \n                    .","journal-title":"Mol Biosyst"},{"key":"1089_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.biochi.2010.003","author":"P Rondeau","year":"2011","unstructured":"Rondeau P, Bourdon E. The glycation of albumin: structural and functional impacts. Biochimie. 2011. doi:\n                        10.1016\/j.biochi.2010.003\n                        \n                    .","journal-title":"Biochimie"},{"key":"1089_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/2251-6581-13-49","author":"A Arasteh","year":"2014","unstructured":"Arasteh A, Farahi S, Habibi-Rezaei M, Moosavi-Movahedi A. Glycated albumin: an overview of the In Vitro models of an In Vivo potential disease marker. J Diabetes Metab Disord. 2014. doi:\n                        10.1186\/2251-6581-13-49\n                        \n                    .","journal-title":"J Diabetes Metab Disord"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00011-017-1089-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-017-1089-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-017-1089-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,3]],"date-time":"2018-01-03T04:40:13Z","timestamp":1514954413000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00011-017-1089-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,11]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["1089"],"URL":"https:\/\/doi.org\/10.1007\/s00011-017-1089-4","relation":{},"ISSN":["1023-3830","1420-908X"],"issn-type":[{"value":"1023-3830","type":"print"},{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,11]]}}}